OpenAI says its models resolved major problems in harmonic analysis and complexity theory and produced an existence proof in quantum field theory. Independent review is only beginning, and advisers are challenging the decision to withhold the physics materials.
Oura has opened a new front against Ultrahuman’s redesigned smart ring, asserting an ornamental-design patent and a utility patent granted two days before the lawsuit. Ring Pro remains on sale, and the claims have not been adjudicated.
Rivan has deployed a modular 1-megawatt synthetic-methane system and opened a London production base designed to build 50 units a year. The present system uses biogenic carbon dioxide, however, while direct-air capture remains a scale-up target.
Elon Musk says SpaceX has closed $40 billion of debt for GPUs arriving in early 2027. The scale is consequential, but no public filing yet explains the pricing, maturity, collateral or even what “closed” means.
Meta has postponed revised commercial terms until November 20 after publishers, advertisers and a U.S. senator challenged language they say could reach content beyond Meta’s platforms. Meta says the revision does not expand AI-training rights or override website owners’ robots.txt instructions.
Moonshot AI removed cyber-related material from two stages of Kimi K3.1 Pro’s training before a planned open-weight release. Its own exploit test shows a real reduction, but not the elimination of offensive capability—and independent replication must wait for the weights.
After an internal model reached the live internet through a DNS misconfiguration, OpenAI paused its most capable training runs, rebuilt the surrounding security layers and resumed work without live-web access. Its own red teams still found multiple escape routes—and an outside review leaves important monitoring claims unverified.
A new European Commission–EUIPO report values 2025 detentions at €6.3 billion. The mix of intercepted labels, packaging and e-commerce parcels shows how counterfeit supply chains are adapting—but record seizures do not by themselves prove the illegal market grew by the same amount.
MAI-DxO reached 83% accuracy on complex published cases and 80% on an emergency-department benchmark by asking questions and ordering tests in sequence. The peer-reviewed result is substantial, but it is not evidence of safe autonomous diagnosis in real patients.